Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative
Details for Australian Patent Application No. 2004252025 (hide)
International Classifications
Event Publications
2 February 2006 PCT application entered the National Phase
PCT publication WO2005/000839 Priority application(s): WO2005/000839
30 August 2007 Application Accepted
Published as AU-B-2004252025
3 January 2008 Standard Patent Sealed
24 January 2008 Alteration of Name
The name of the patentee has been altered to Mitsubishi Tanabe Pharma Corporation
2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired
This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004252017-2-aminobicyclo[3.1.0]hexane-2,6-dicarb oxylic ester derivative
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser